Security key
695127100
Pacira BioSciences, Inc. - Common Stock (PCRX)
CUSIP: 695127100
Q4 2016 13F Holders as of 31 Dec 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 40,532,351
- Total 13F shares
- 40,261,661
- Share change
- +614,924
- Total reported value
- $1,300,363,433
- Put/Call ratio
- 104%
- Price per share
- $32.30
- Number of holders
- 178
- Value change
- +$16,595,121
- Number of buys
- 86
- Number of sells
- 88
Report period
Q4 2016
Institutions
178
Top holders
10
PCRX full security history
Newer quarter: Q1 2017
Previous quarter: Q3 2016
Pacira BioSciences, Inc. SEC filings
Pacira BioSciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 695127100
Recent filing periods:
Top shareholders of PCRX - Pacira BioSciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
11%
|
4,300,854
|
$147,175,000 | — | 30 Sep 2016 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
8.3%
|
3,377,591
|
$115,581,000 | — | 30 Sep 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.6%
|
2,667,211
|
$91,272,000 | — | 30 Sep 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
4.2%
|
1,682,381
|
$57,571,000 | — | 30 Sep 2016 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
3.7%
|
1,481,461
|
$50,696,000 | — | 30 Sep 2016 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.2%
|
1,308,529
|
$44,778,000 | — | 30 Sep 2016 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
3.1%
|
1,238,408
|
$42,378,000 | — | 30 Sep 2016 | |
| DARUMA CAPITAL MANAGEMENT LLC |
13F
|
Company |
3%
|
1,220,044
|
$41,750,000 | — | 30 Sep 2016 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2.8%
|
1,147,579
|
$39,270,000 | — | 30 Sep 2016 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
1,098,184
|
$37,584,000 | — | 30 Sep 2016 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.7%
|
1,086,935
|
$37,195,000 | — | 30 Sep 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
2.3%
|
943,934
|
$32,301,000 | — | 30 Sep 2016 | |
| NEXT CENTURY GROWTH INVESTORS LLC |
13F
|
Company |
1.9%
|
778,442
|
$26,638,000 | — | 30 Sep 2016 | |
| Standard Investments LLC |
13F
|
Company |
1.9%
|
775,388
|
$26,534,000 | — | 30 Sep 2016 | |
| HealthCor Management, L.P. |
13F
|
Company |
1.8%
|
744,280
|
$25,469,000 | — | 30 Sep 2016 | |
| OAK RIDGE INVESTMENTS LLC |
13F
|
Company |
1.8%
|
721,934
|
$24,705,000 | — | 30 Sep 2016 | |
| Granahan Investment Management, LLC |
13F
|
Company |
1.7%
|
670,610
|
$22,948,000 | — | 30 Sep 2016 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
1.6%
|
663,456
|
$22,703,000 | — | 30 Sep 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.6%
|
637,651
|
$21,818,000 | — | 30 Sep 2016 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
1.5%
|
618,505
|
$21,165,000 | — | 30 Sep 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.5%
|
611,044
|
$20,910,000 | — | 30 Sep 2016 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
540,405
|
$18,492,000 | — | 30 Sep 2016 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.2%
|
504,000
|
$17,247,000 | — | 30 Sep 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
475,649
|
$16,277,000 | — | 30 Sep 2016 | |
| Elk Creek Partners, LLC |
13F
|
Company |
1.1%
|
458,448
|
$15,688,000 | — | 30 Sep 2016 | |
| Sarissa Capital Management LP |
13F
|
Company |
1.1%
|
430,000
|
$14,714,000 | — | 30 Sep 2016 | |
| NORGES BANK |
13F
|
Company |
1%
|
410,467
|
$13,416,000 | — | 30 Sep 2016 | |
| PointState Capital LP |
13F
|
Company |
1%
|
408,500
|
$13,979,000 | — | 30 Sep 2016 | |
| Tamarack Advisers, LP |
13F
|
Company |
0.99%
|
400,000
|
$14,164,000 | — | 30 Sep 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.92%
|
372,052
|
$12,732,000 | — | 30 Sep 2016 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.89%
|
361,930
|
$12,385,000 | — | 30 Sep 2016 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.87%
|
351,978
|
$12,045,000 | — | 30 Sep 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.77%
|
310,281
|
$10,617,000 | — | 30 Sep 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.74%
|
300,452
|
$10,280,000 | — | 30 Sep 2016 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.68%
|
274,862
|
$9,406,000 | — | 30 Sep 2016 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.66%
|
268,000
|
$9,171,000 | — | 30 Sep 2016 | |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO |
13F
|
Company |
0.55%
|
223,453
|
$7,647,000 | — | 30 Sep 2016 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.53%
|
213,600
|
$7,309,000 | — | 30 Sep 2016 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.47%
|
192,090
|
$6,573,000 | — | 30 Sep 2016 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.47%
|
191,546
|
$6,555,000 | — | 30 Sep 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.47%
|
189,761
|
$6,494,000 | — | 30 Sep 2016 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.44%
|
179,139
|
$6,130,000 | — | 30 Sep 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.44%
|
176,725
|
$6,048,000 | — | 30 Sep 2016 | |
| Biondo Investment Advisors, LLC |
13F
|
Company |
0.4%
|
163,073
|
$5,580,000 | — | 30 Sep 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.4%
|
161,915
|
$5,541,000 | — | 30 Sep 2016 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.38%
|
153,122
|
$5,239,000 | — | 30 Sep 2016 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.37%
|
150,680
|
$5,156,000 | — | 30 Sep 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.37%
|
149,803
|
$5,126,000 | — | 30 Sep 2016 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.36%
|
147,749
|
$5,056,000 | — | 30 Sep 2016 | |
| Key Colony Management, LLC |
13F
|
Company |
0.34%
|
139,000
|
$4,757,000 | — | 30 Sep 2016 |
Institutional Holders of Pacira BioSciences, Inc. - Common Stock (PCRX) as of Q4 2016
As of 31 Dec 2016,
Pacira BioSciences, Inc. - Common Stock (PCRX) was held by
178 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,261,661 shares.
The largest 10 holders included
VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Fund Advisors, FMR LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, HealthCor Management, L.P., GILDER GAGNON HOWE & CO LLC, DARUMA CAPITAL MANAGEMENT LLC, Partner Fund Management, L.P., and Clearbridge Investments, LLC.
This page lists
178
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
176
Q4 2016 holders
178
Holder diff
2
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 Value $ | Q4 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.